The Global Impurity Control: Genotoxicity, Nitrosamines, and Beyond 2026 Conference is a premier two-day event dedicated to advancing strategies for identifying, assessing, and managing impurities throughout the drug development lifecycle.
Designed for professionals in pharmaceutical sciences, regulatory affairs, toxicology, analytical chemistry, and other related fields, this conference will explore a comprehensive range of topics including:
- Advanced analytical techniques like high-resolution mass spectrometry for impurity detection
- Risk-based and regulatory-compliant strategies for managing genotoxic and nitrosamine impurities
- Modern genotoxicity testing including in vitro, in vivo, and in silico methods
- Emerging contaminants and their safety impact
- Focus on biologics, APIs, and combination products
- Formulation design and development strategies aimed at minimizing impurity risks
- Use of AI and machine learning to improve genotoxicity testing and risk assessment
Attendees will benefit from expert insights, real-world case studies, and collaborative discussions on optimizing impurity control and formulation strategies, navigating complex regulatory requirements, and embracing cutting-edge technologies like AI and automation.
Alongside the expert-led sessions, the event offers rich opportunities for networking — allowing participants to connect with peers, engage with thought leaders, and form partnerships that extend beyond the conference.
Over the course of two days, you can expect dynamic keynote presentations, expert-led panels, and meaningful networking opportunities — all designed to spark dialogue and drive innovation. Whether you are focused on R&D, regulatory affairs, quality assurance, analytics, toxicology, manufacturing, data science, or other specialized areas, this event is crafted to inform, connect, and inspire.
Join us to stay at the forefront of impurity control and strengthen your ability to navigate the complexities of this crucial area in pharmaceutical development.
